Диссертация (1154746), страница 17
Текст из файла (страница 17)
30-34.128. Edye M.E., Brough D., Allan S.M. Acid-dependent Interleukin-1 (IL-1)Cleavage Limits Available Pro-IL-1β for Caspase-1 Cleavage // J Biol Chem.2015. N 16; 290 (V 42). p. 25374-25381.129. Einarsdottir E., Carlsson A., Minde J., Toolanen G., Svensson O., SoldersG., Holmgren G., Holmberg D., Holmberg M. A mutation in the nerve growthfactor beta gene (NGFB) causes loss of pain perception // Hum. Mol. Genet.
–2004, - V 13, - N 8. – P. 799-805.130. Emanueli C., Schratzberger P., Kirchmair R., Madeddu P. Paracrine controlof vascularization and neurogenesis by neurotrophins // Br J Pharmacol. – 2003, V 140, - N 4. – P. 614-619.131. Endres M., Fan G., Hirt L., Jaenisch R. Stroke damage in mice afterknocking the neutrophin-4 gene into the brain-derived neurotrophic factor locus // JCereb. Blood Flow Metab. – 2003, - V 23, - N 2.
– P. 150-153.112132. Erdos E.G., Skidgel R.A. Angiotensin-I-converting enzyme // Lab. Inuest. –1987. – 56, – N 4. – P. 345-348.133. Escot C., Zhao Y., Puech C., Rochefort H. Cellular localisation by in situhybridisation of cathepsin D, stromelysin 3, and urokinase plasminogen activatorRNAs in - breast cancer // Breast Cancer Res. Treat.
1996. N 38. p. 217–226.134. Fahnestock M., Yu G., Coughlin M.D. ProNGF: a neurotrophic or anapoptotic molecule? // Prog. Brain Res. – 2004, - V 146. – P. 107-110.135. Falfushynska H.I., Gnatyshyna L.L., Deneha H.V., Osadchuk O.Y., StoliarO.B. Manifestations of oxidative stress and molecular damages in ovarian cancertissue // Ukr Biochem J. 2015. V 87. N 5.
p. 93-102.136. Feng Y.X., Zhao J.S., Li J.J., Wang T., Cheng S.Q., Yuan Y., Wang F.,Wang X.F., Xie D. Liver cancer: EphrinA2 promotes tumorigenicity throughRac1/Akt/NF-kappaB signaling pathway 120 // Hepatology. – 2010, - V 51. – N 2.– P. 535-544.137. Ferrandina G., Scambia G., Bardelli F., Panici B., Mancuso S., Messori A.Relationship between cathepsin-D content and disease-free survival in nodenegative breast cancer patients: a meta-analysis // Br. J. Cancer/ 1997.
N 76. p.661–666.138. Ferrazzani S., Leardi P., Magnotti D.L., De Carolis S., Moneta E., PorcelliG., Volpe A.R., Menini E., Liberale I. Aldosterone, kallikrein, kininase I and II innormal and hypertension complicated pregnancy // Adv. Exp. Med. Biol. – 1989, V 247. – P. 455-461.139. Fiedorek F.T.Jr., Parkinson D. Carboxypeptidase H processing and secretionin rat clonal beta-cell lines // Endocrinology. – 1992. – V. 131, № 3. – P. 10541062.140.
Figiel M., Maucher T., Rozyczka J., Bayatti N., Engele J. Regulation of glialglutamate transporter expression by growth factors // Exp Neurol. – 2003. – V 183,- N 1. – P. 124-135.141. Florholmen G., Andersson K.B., Yndestad A., Austbo B., Henriksen U.L.,Christensen G. Leukaemia inhibitory factor alters expression of genes involved in113rat cardiomyocyte energy metabolism // Acta Physiol. Scand. – 2004, - V 180, - N2. – P. 133-142.142. Foekens J.A., Look M.P., Bolt-de Vries J., Meijer-van Gelder M., van PuttenW.L.J., Klijn J.G.M. Cathepsin D in primary breast cancer: prognostic evaluationinvolving 2810 patients // Br.
J. Cancer. 2015. N 79. p. 300–307.143. Foster E.S., Kimber I., Dearman R.J. Relationship between proteindigestibility and allergenicity: comparisons of pepsin and cathepsin // Toxicology.2013. N 5, V 309. p. 30-38.144. Fraticante L.I., Rotrosen I., Siekiorski I., Fracer H., Gershon S. EnkephalininactivationbyN-terminaltyrosinecleavage:purificationandpartialcharacterisation of a highly specific enzyme from human brain // Life Sci.
– 1980.– 26, N 20. – P. 1697-1706.145. Freeman R.S., Burch R.L., Crowder R.J., Lomb D.J., Schoell M.C., StraubJ.A., Xie L. NGF deprivation-induced gene expression: after ten years, where dowe stand? // Prog. Brain Res. – 2004, - V 146. – P. 111-126.146. Freire C., Ramos R., Amaya E., Fernández M.F., Santiago-Fernández P.,Lopez-Espinosa M.J., Arrebola J.P., Olea N. Newborn TSH concentration and itsassociation with cognitive development in healthy boys // Eur. J Endocrinol.
–2010,- V 163, - N 6. – P. 901-909.147. Fricker L.D. Neuropeptide-Processing Enzymes: Applications for DrugDiscovery // AAPS Journal. – 2005, - V. 07, - N 02. – P. 449-455.148. Fricker L.D. Neuropeptidomics to Study Peptide Processing in AnimalModels of Obesity // Endocrinology. – 2007, - V. 148, - N 9. - P. 4185-4190149. Fricker L.D., Adelman J.P., Douglass J., Thompson R.C, von StrandmannR.P, Hutton J AD.
Isolation and sequence analysis of cDNA for ratcarboxypeptidase E [EC 3.4.17.10], a neuropeptide processing enzyme // Mol.Endocrinol. – 1989. – 3, N 4. – P. 666-673.150. Fricker L.D., Berman Y.L., Leiter E.H., Devi L.A. Carboxypeptidase Eactivity is deficient in mice with the fat mutation. Effect on peptide processing // J.Biol. Chem. – 1996. – 271, N 48. – P. 30619-30624.114151. Fricker L.D., Das B., Angeletti R.H. Identification of the pH dependentmembrane anchor of carboxypeptidase E (EC 3.4.17.10) // J. Biol. Chem. – 1990. –265, N 5. – P.
2476-2282.152. Fricker L.D., Das B., Klein R.S., Greene D., Jung Y.K. Regulation ofcarboxypeptidase E (enkephalin convertase) // NIDA Res. Monogr. – 1991. – №111. – P. 171-187.153. Fricker L.D., Rigual R.J., Diliberto E.J.Jr., Viveros O.H. Reflex splanchnicnerve stimulation increases levels of carboxypeptidase E mRNA and enzymaticactivity in the rat adrenal medulla // J. Neurochem. – 1990.
– 55, N 2. – P. 461467.154. Fricker L.D., Snyder S.H. Enkephalin convertase: purification andcharasterization of a specific enkephalin-synthesizing carboxypeptidase localizedto adrenall chromaffin granules // Proc. Natl. Acad. Sci. USA. – 1982. – 79. – P.3886-3890.155. Fricker L.D., Snyder S.H. Purification and characterization of enkephalinconvertase, an enkephaline-synthesizing carboxypeptidase // J. Biol. Chem. –1983. – 258, N 18. – P.
10950-10955.156. Friguls B., Petegnief V., Justicia C., Pallas M., Planas A.M. Activation ofERK and Akt signaling in focal cerebral ischemia: modulation by TGF-alpha andinvolvement of NMDA receptor // Neurobiol. Dis. – 2002, - V 11, - N 3. – P. 443456.157. Fu P., Sodian R., Luders C., Lemke T., Kraemer L. Effects of basicfibroblast growth factor and transforming growth factor-beta on maturation ofhuman pediatric aortic cell culture for tissue engineering of cardiovascularstructures // Asaio J. – 2004, - V 50, - N 1. – P.
9-14.158. Gabriel C., Ali C., Lesne S., Fernandez-Monreal M., Docagne F., PlawinskiL., Buisson A., Vivien D. Transforming growth factor alpha-induced expression oftype 1 plasminogen activator inhibitor in astrocytes rescues neurons fromexcitotoxicity // FASEB J. – 2003, - V 17, - N 2. – P. 277-279.115159.
Gainer H., Russel J.T., Loh Y.P. The enzymology and intracellularorganization of peptide precursor processing: the secretory vesicle hypothesis //Neuroendocrinology. - 1985. – 40, N 1. – P. 171-184.160. Gallagher S.P. Oconnor B. A Study of a highly specific pyroglutamylaminopeptidase type-II from the membrane fraction of bovine brain // Int.
J.Biochem. Cell Biol. – 1998. – 30, N 1. – P. 115-133.161. García-García F., Acosta-Peña E., Venebra-Muñoz A., Murillo-Rodríguez E.Sleep-inducing factors // CNS Neurol Disord Drug Targets. – 2009, - V 8, - N 4, P. 235-244.162. Gardell L.R., Wang R., Ehrenfels C., Ossipov M.H., Rossomando A.J.Multiple actions of systemic artemin in experimental neuropathy // Nat. Med. –2003, - V 9, - N 11.
– P. 1383-1389.163. Gibson A.M., Biggins J.A., Lauffart B., Mantle D., McDermott J.R. Humanbrain leucyl aminopeptidase: Isolation, characterization and specificity againstsome neuropeptides // Neuropeptides. – 1991. – 19, N 3. – P. 163-168.164. Glebova N.O., Ginty D.D. Heterogeneous requirement of NGF forsympathetic target innervation in vivo // J Neurosci. – 2004, - V 24, - N 3. – P.743-751.165.
Golden J.P., Milbrandt J., Johnson E.M. Neurturin and persephin promotethe survival of embryonic basal forebrain cholinergic neurons in vitro // ExpNeurol. – 2003, - V 184, - N 1. – P. 447-455.166. Granato M., Lacconi V., Peddis M., Lotti L.V., Di Renzo L., et. al.
HSP70inhibition by 2-phenylethynesulfonamide induces lysosomal cathepsin D releaseand immunogenic cell death in primary effusion lymphoma // Cell Death Dis.2013. N 18;4. p. 730.167. Grazul-Bilska A.T., Johnson M.L., Bilski J.J., Redmer D.A., Reynolds L.P.,Abdullah A., Abdullah K.M. Wound healing: the role of growth factors // DrugsToday (Barc). – 2003, - V 39, - N 10.
– P. 787-800.116168. Grondin R., Zhang Z., Ai Y., Gash D.M., Gerhardt G.A. Intracranialdelivery of proteins and peptides as a therapy for neurodegenerative diseases //Prog. Drug Res. – 2003, - V 61. – P. 101-123.169. Grupp L.A. Effects of angiotensin II and an angiotensin converting enzymeinhibitor on alcochol intake in P and NP rats // Pharmacol. Biochem. Behav. –1992. – 41, N 1. – P. 105-108.170.
Guest P.C., Arden S.D., Rutherford N.G., Hutton J.C. The posttranslationalprocessing and intracellular sorting of carboxypeptidase H in the islets ofLangerhans // Mol. Cell. Endocrinol. – 1995. – 113, N 1, P. 99-108.171. Guest P.C., Ravazzola M., Davidson H.W., Orci L., Hutton J.C. Molecularheterogeneity and cellular localization of carboxypeptidase H in the islets ofLangerhans // Endocrinology. – 1991.
– 129, N 2. – P. 734-740.172. Gui L, Zeng Q, Xu Z, Zhang H, Qin S, et. al. IL-2, IL-4, IFN-γ or TNF-αenhances BAFF-stimulated cell viability and survival by activating Erk1/2 andS6K1 pathways in neoplastic B-lymphoid cells // Cytokine. 2016. N 25. (84). p.37-46.173. Hamilton J.A., Whitty G., White A.R., Jobling M.F., Thompson A., BarrowC.J. Alzheimer's disease amyloid beta and prion protein amyloidogenic peptidespromote macrophage survival, DNA synthesis and enhanced proliferative responseto CSF-1 (M-CSF) // Brain Res. – 2002, - V 940, - N 1-2, - P. 49-54.174. Han K.Y., Hwang J.W., Bae G.U., Kim S.N., Kim Y.K. Akt regulation ofAven contributes to the sensitivity of cancer cells to chemotherapeutic agents //Mol Med Rep.
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
